Yong He

13.1k total citations · 1 hit paper
256 papers, 6.8k citations indexed

About

Yong He is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Yong He has authored 256 papers receiving a total of 6.8k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Pulmonary and Respiratory Medicine, 81 papers in Molecular Biology and 77 papers in Oncology. Recurrent topics in Yong He's work include Lung Cancer Treatments and Mutations (62 papers), Lung Cancer Research Studies (19 papers) and Colorectal Cancer Treatments and Studies (17 papers). Yong He is often cited by papers focused on Lung Cancer Treatments and Mutations (62 papers), Lung Cancer Research Studies (19 papers) and Colorectal Cancer Treatments and Studies (17 papers). Yong He collaborates with scholars based in China, United States and United Kingdom. Yong He's co-authors include Suresh S. Ramalingam, Tony Mok, Yi‐Long Wu, Willemijn S.M.E. Theelen, Martin Sebastian, Myung‐Ju Ahn, Frances A. Shepherd, Helen Mann, Hiroaki Akamatsu and Vassiliki A. Papadimitrakopoulou and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Yong He

230 papers receiving 6.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Osimertinib or Platinum–Pemetrexed in EGFR T790M–Positive Lung Cancer

2016 2.4k citations Yi‐Long Wu, Suresh S. Ramalingam et al. profile →

Peers

Yong He

PRM

ONCOL

SURGE

Lin Li China

Jie Wang China

Han‐Shui Hsu Taiwan

Peng Luo China

Navneet Singh India

Yoichi Nakanishi Japan

Dirk Reinhardt Germany

Xianglin Yuan China

Noboru Hattori Japan

Christian Brambilla France

Lin Li China

Yong He

2.7k ×0.8

PRM

2.3k ×0.8

ONCOL

2.1k ×0.9

1.1k ×1.0

503 ×1.2

SURGE

Citations per year, relative to Yong He Yong He (= 1×) peers Lin Li

Countries citing papers authored by Yong He

Since Specialization

Citations

This map shows the geographic impact of Yong He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yong He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yong He more than expected).

Fields of papers citing papers by Yong He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yong He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yong He. The network helps show where Yong He may publish in the future.

Co-authorship network of co-authors of Yong He

This figure shows the co-authorship network connecting the top 25 collaborators of Yong He. A scholar is included among the top collaborators of Yong He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yong He. Yong He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Yu, Yuantao Yang, Yuehan Cao, et al.. (2025). In situ H-bond-mediated intermediate stabilization on Ga2O3/BN for highly selective photocatalytic methane oxidation to methanol. Applied Catalysis B: Environmental. 385. 126333–126333.

Sun, Yue, et al.. (2025). Full-Range, High-Sensitivity, Linear Aerogel Pressure Sensor with Epidermal-Inspired Mechanoreception Networks. Chemical Engineering Journal. 511. 161886–161886. 5 indexed citations

He, Yong, Yi Zheng, Jing Niu, et al.. (2025). Molecular Routes of Coke Species on HZSM-5 Zeolite with Atomic-Resolution Structural Identification. Journal of the American Chemical Society. 147(45). 41379–41389.

Garassino, Marina Chiara, Yong He, Myung‐Ju Ahn, et al.. (2025). Osimertinib long-term tolerability in patients with EGFRm NSCLC enrolled in the AURA program or FLAURA study. Lung Cancer. 202. 108417–108417.

Zhang, Yan, Xiaosong Tian, Dongjie Guan, et al.. (2024). Evolutionary Trend Analysis of Agricultural Non-Point Source Pollution Load in Chongqing Based on Land Use Simulation. Agronomy. 14(4). 737–737. 2 indexed citations

Dai, Yang, Yan Wang, Xinyue Yang, et al.. (2023). Assessment of post-COVID-19 fatigue among female survivors 2 years after hospital discharge: a nested case–control study. BMC Public Health. 23(1). 2455–2455. 3 indexed citations

Chang, Lei, Lisheng Chen, Yong He, et al.. (2023). Integrated network pharmacology and metabolomics to investigate the effects and possible mechanisms of Dehydroevodiamine against ethanol-induced gastric ulcers. Journal of Ethnopharmacology. 319(Pt 3). 117340–117340. 11 indexed citations

Zheng, Nan, Yimin Zhang, Qiang Ma, et al.. (2023). Pathological Response and Tumor Immune Microenvironment Remodeling Upon Neoadjuvant ALK-TKI Treatment in ALK-Rearranged Non-Small Cell Lung Cancer. Targeted Oncology. 18(4). 625–636. 5 indexed citations

Han, Rui, Yimin Zhang, Tianhu Wang, et al.. (2023). Tumor immune microenvironment predicts the pathologic response of neoadjuvant chemoimmunotherapy in non–small‐cell lung cancer. Cancer Science. 114(6). 2569–2583. 13 indexed citations

10.

Wang, Yang, Li Chen, Lu Wang, et al.. (2023). Pulsed Electromagnetic Fields Combined With Adipose-Derived Stem Cells Protect Ischemic Myocardium by Regulating miR-20a-5p/E2F1/p73 Signaling. Stem Cells. 41(7). 724–737. 5 indexed citations

11.

Zhang, Yongchang, Rui Han, Yubo Wang, et al.. (2022). The rational application of liquid biopsy based on next‐generation sequencing in advanced non‐small cell lung cancer. Cancer Medicine. 12(5). 5603–5614. 4 indexed citations

12.

Hu, Chen, Yukai Liu, Yuqiang Fang, et al.. (2022). Clinical characteristics and risk factors for a prolonged length of stay of patients with asymptomatic and mild COVID-19 during the wave of Omicron from Shanghai, China. BMC Infectious Diseases. 22(1). 947–947. 2 indexed citations

13.

Zhu, Lei, Zhen Chen, Hongjing Zang, et al.. (2021). Targeting c-Myc to Overcome Acquired Resistance of EGFR Mutant NSCLC Cells to the Third-Generation EGFR Tyrosine Kinase Inhibitor, Osimertinib. Cancer Research. 81(18). 4822–4834. 50 indexed citations

14.

Cheng, Ying, Yong He, Wěi Li, et al.. (2021). Osimertinib Versus Comparator EGFR TKI as First-Line Treatment for EGFR-Mutated Advanced NSCLC: FLAURA China, A Randomized Study. Targeted Oncology. 16(2). 165–176. 90 indexed citations

15.

Chen, Hengyi, Conghua Lu, Caiyu Lin, et al.. (2021). VPS34 suppression reverses osimertinib resistance via simultaneously inhibiting glycolysis and autophagy. Carcinogenesis. 42(6). 880–890. 9 indexed citations

16.

Chen, Hengyi, Caiyu Lin, Tao Peng, et al.. (2020). Metformin reduces HGF-induced resistance to alectinib via the inhibition of Gab1. Cell Death and Disease. 11(2). 111–111. 20 indexed citations

17.

Wu, Liusheng, Haifeng Wang, Jing Fan, et al.. (2019). Comparison of Double Sleeve Lobectomy by Uniportal Video-Assisted Thoracic Surgery (VATS) and Thoracotomy for NSCLC Treatment. SHILAP Revista de lepidopterología. 4 indexed citations

18.

Wang, Hua, Shuang Zhao, Xiaozhu Zhang, et al.. (2019). Major histocompatibility complex class II molecule in non-small cell lung cancer diagnosis, prognosis and treatment. SHILAP Revista de lepidopterología. 1 indexed citations

19.

Liu, Qiuli, Dali Tong, Gaolei Liu, et al.. (2018). Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration. Clinical Cancer Research. 24(22). 5622–5634. 86 indexed citations

20.

Li, Li, Rui Han, Hualiang Xiao, et al.. (2014). Metformin Sensitizes EGFR-TKI–Resistant Human Lung Cancer Cells In Vitro and In Vivo through Inhibition of IL-6 Signaling and EMT Reversal. Clinical Cancer Research. 20(10). 2714–2726. 204 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact